Skip to content

AJAY DARA

  • PhD Scholar
  • National Institute of Pharmaceutical Education & Research (NIPER)
  • 18PublicationsNumber of items in AJAY's My Publications folder on Mendeley.
  • 95Followers

Recent publications

  • Anti-Cancer patent landscape and technology assessment of Indian public funded research institutes and organizations

    • Dara Ajay
    • Abhay T. Sangamwar
    N/AReaders
    N/ACitations
  • Clearing the Fog of Anticancer Patents from 1993–2013: Through an In-Depth Technology Landscape & Target Analysis from Pioneer Research Institutes and Universities Worldwide

    • Ajay Dara
    • Abhay T Sangamwar
    N/AReaders
    N/ACitations

Professional experience

PhD Scholar

National Institute of Pharmaceutical Education & Research (NIPER)

June 2011 - Present

Research scholar (JRF)

The Council of Scientific and Industrial Research (CSIR)

September 2010 - May 2011(8 months)

Education

M.S. (Pharm) specilisation Pharmacoinformatics

National Institute of Pharmaceutical Education & Research (NIPER)

August 2008 - June 2010(2 years)

Bachelor of pharmacy

Osmania University

March 2004 - June 2008(4 years)

About

I’m a registered pharmacist and a patent analysts, expert in information retrieval and landscape analysis. My professional interest lies in both patent research (Patinformatics Tools, Patent Analysis, IP valuation) as well as business competitive intelligences through due diligence and Technology Transfer The following are the prime focus areas that have been extensively dealt with • Intellectual Property Management-Pharma Patents, Technology Landscape Analysis • Competitive Intelligence, Whitespace Analysis, Claim Mapping, Data Clustering • Due Diligence, Freedom to Operate (FTO), Infringement and Invalidation studies • Prior Art Search, Preparing Patentability Report, Patent Drafting, Patent Docketing • Patent Prosecution, Portfolio Analysis and basics of IP valuation • Licensing & Technology Transfer agreements like MTAs, NDAs, MOUs, IIAs etc. • Bio/Chemoinfomatics, Drug design by Molecular modeling-Docking, Homology modeling • Virtual screening, QSAR, Pharmacophore and ADME/Toxicity predictions • Molecular Dynamics (MD) simulations, Quantum mechanics – optimizations and QM/MM calculations

Followers (95)

Explore network

Following (99)

Explore network